Picture of Aardvark Therapeutics logo

AARD Aardvark Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Aardvark Therapeutics pauses late-stage trial testing rare disease treatment

Feb 27 (Reuters) - Aardvark Therapeutics AARD.O on Friday said it is voluntarily pausing its late-stage trial testing its experimental treatment for a type of rare genetic disease.

 (Reporting by Sneha  S K; Editing by Maju Samuel)

 ((Sneha.SK@thomsonreuters.com;))

Recent news on Aardvark Therapeutics

See all news